Exponent Inc (EXPO)

Net profit margin

Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Net income US$ in thousands 109,002 100,339 102,330 101,202 82,552
Revenue US$ in thousands 558,514 536,766 513,293 466,269 399,900
Net profit margin 19.52% 18.69% 19.94% 21.70% 20.64%

December 31, 2024 calculation

Net profit margin = Net income ÷ Revenue
= $109,002K ÷ $558,514K
= 19.52%

To analyze Exponent Inc's net profit margin over the five-year period from December 31, 2020, to December 31, 2024, we observe the following trends:

- The net profit margin has shown some fluctuations during this period. It started at 20.64% in 2020, increased to 21.70% in 2021, then decreased to 19.94% in 2022, further declined to 18.69% in 2023, and finally rose to 19.52% in 2024.

- The net profit margin measures the percentage of revenue that transforms into profit after accounting for all expenses. A higher net profit margin indicates that the company is better at converting revenue into profit.

- The company's net profit margin peaked in 2021 at 21.70% before experiencing a downward trend in the following years.

- The fluctuations in the net profit margin could be attributed to changes in the company's cost structure, pricing strategies, operational efficiency, or external economic factors influencing revenue and expenses.

- Overall, despite the fluctuations, Exponent Inc has maintained a relatively healthy net profit margin range over the five-year period, indicating a reasonable ability to generate profit from its operations. However, monitoring and analyzing the underlying factors driving these fluctuations would be essential for sustainable financial performance.

In conclusion, Exponent Inc's net profit margin analysis highlights the company's performance in generating profit relative to its revenue, showcasing both strengths and areas that may require further monitoring and improvement.


Peer comparison

Dec 31, 2024

Company name
Symbol
Net profit margin
Exponent Inc
EXPO
19.52%
FTI Consulting Inc
FCN
7.57%
Genpact Limited
G
10.78%